Kane Biotech Pink Sheet Forecast - Naive Prediction

Kane Biotech Additional Predictive Modules

Most predictive techniques to examine Kane price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kane using various technical indicators. When you analyze Kane charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur. A naive forecasting model for Kane Biotech is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Kane Biotech value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Kane Biotech Naive Prediction Price Forecast For the 27th of January

Given 90 days horizon, the Naive Prediction forecasted value of Kane Biotech on the next trading day is expected to be 0.03 with a mean absolute deviation of 0, mean absolute percentage error of 0.0000019, and the sum of the absolute errors of 0.06.

Kane Biotech Pink Sheet Forecast Pattern

Backtest Kane Biotech

Kane Biotech Price Prediction

Buy or Sell Advice

Kane Biotech Forecasted Value

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Kane Biotech pink sheet data series using in forecasting. Note that when a statistical model is used to represent Kane Biotech pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. This model is not at all useful as a medium-long range forecasting tool of Kane Biotech. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Kane Biotech. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Kane Biotech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kane Biotech. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.00 0.03 5.55 Details

Intrinsic Valuation Low Real High 0.00 0.02 5.54 Details

Bollinger Band Projection (param) Low Middle High 0.02 0.03 0.03 Details

Kane Biotech After-Hype Price Density Analysis

Kane Biotech Estimiated After-Hype Price Volatility

Kane Biotech Pink Sheet Price Outlook Analysis

Notes

Kane Biotech Hype Timeline

Kane Biotech is now traded for 0.03. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Kane is forecasted to decline in value after the next headline, with the price expected to drop to 0.03. The average volatility of media hype impact on the company price is insignificant. The price reduction on the next news is expected to be -3.23%, whereas the daily expected return is now at 0.26%. The volatility of related hype on Kane Biotech is about 632954.55%, with the expected price after the next announcement by competition of 0.03. About 27.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.03. Kane Biotech last dividend was issued on the 13th of March 2017. The entity had 1:5 split on the 13th of March 2017. Assuming the 90 days horizon the next forecasted press release will be uncertain. Check out Historical Fundamental Analysis of Kane Biotech to cross-verify your projections.

Kane Biotech Related Hype Analysis

Other Forecasting Options for Kane Biotech

For every potential investor in Kane, whether a beginner or expert, Kane Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Kane Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Kane. Basic forecasting techniques help filter out the noise by identifying Kane Biotech's price trends.

Kane Biotech Related Equities

Risk & Return

Correlation

Kane Biotech Market Strength Events

Kane Biotech Risk Indicators

Story Coverage note for Kane Biotech

Other Macroaxis Stories

Other Information on Investing in Kane Pink Sheet